N-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)-2-(4-methylpiperazin-1-yl)acetamide

ID: ALA4068419

PubChem CID: 39070491

Max Phase: Preclinical

Molecular Formula: C19H20N4O3

Molecular Weight: 352.39

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CN1CCN(CC(=O)NN2C(=O)c3cccc4cccc(c34)C2=O)CC1

Standard InChI:  InChI=1S/C19H20N4O3/c1-21-8-10-22(11-9-21)12-16(24)20-23-18(25)14-6-2-4-13-5-3-7-15(17(13)14)19(23)26/h2-7H,8-12H2,1H3,(H,20,24)

Standard InChI Key:  ZMFRDLXFYYZBRG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   15.3106   -8.4525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3095   -9.2762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0198   -8.0437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7285   -8.4489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1543   -9.2683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1495   -8.4421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4363   -8.0387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7292   -9.2721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0221   -9.6842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0218  -10.5002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7270  -10.9103    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.4383  -10.5023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4402   -9.6801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3093  -10.9076    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.1496  -10.9118    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.7257  -11.7316    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.4368  -12.1455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4354  -12.9668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1493  -11.7340    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.1465  -13.3766    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.1396  -14.1986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8467  -14.6124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5616  -14.2044    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.5650  -13.3821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8534  -12.9679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2712  -14.6210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  9  1  0
  4  3  2  0
  3  1  1  0
  4  8  1  0
 13  5  2  0
  5  6  1  0
  6  7  2  0
  7  4  1  0
  8  9  2  0
  8 13  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 10 14  2  0
 12 15  2  0
 11 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 18 20  1  0
 20 21  1  0
 20 25  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 23 26  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4068419

   N-(1,3-dioxobenzo[de]isoquinolin-2-yl)-2-(4-methylpiperazin-1-yl)acetamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 352.39

Molecular Weight (Monoisotopic): 352.1535

AlogP: 0.71

#Rotatable Bonds: 3

Polar Surface Area: 72.96

Molecular Species: NEUTRAL

HBA: 5

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 9.75

CX Basic pKa: 7.19

CX LogP: 0.83

CX LogD: 0.62

Aromatic Rings: 2

Heavy Atoms: 26

QED Weighted: 0.82

Np Likeness Score: -1.29

References

1. Klimenko K, Lyakhov S, Shibinskaya M, Karpenko A, Marcou G, Horvath D, Zenkova M, Goncharova E, Amirkhanov R, Krysko A, Andronati S, Levandovskiy I, Polishchuk P, Kuz'min V, Varnek A..  (2017)  Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents.,  27  (16): [PMID:28666733] [10.1016/j.bmcl.2017.06.035]

Source

Source(1):

• Scientific Literature